Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025PRNewsWire • 01/08/25
Down -11.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Haemonetics (HAE)Zacks Investment Research • 12/23/24
Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High?Zacks Investment Research • 12/04/24
Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS?Zacks Investment Research • 12/04/24
Wall Street Analysts Think Haemonetics (HAE) Could Surge 25.58%: Read This Before Placing a BetZacks Investment Research • 11/11/24
Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins ExpandZacks Investment Research • 11/11/24
Compared to Estimates, Haemonetics (HAE) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 11/07/24
Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations WebsitePRNewsWire • 11/07/24
Haemonetics (HAE) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance MeasuresZacks Investment Research • 11/06/24
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024PRNewsWire • 10/03/24
After Plunging -15.88% in 4 Weeks, Here's Why the Trend Might Reverse for Haemonetics (HAE)Zacks Investment Research • 09/02/24